| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10968572 | Vaccine | 2012 | 6 Pages |
Abstract
⺠Health problems detected were comparable with baseline data of the districts. ⺠Documented safety profile consistent with monovalent PS conjugate vaccine (ex: Hib). ⺠No outstanding safety issue with MenAfriVacâ¢. ⺠Hypersensitivity reactions require further assessment to rule out anaphylactic reactions.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Claude-Roger Ouandaogo, Téné M. Yaméogo, Fabien V.K. Diomandé, Charles Sawadogo, Bassirou Ouédraogo, Rasmata Ouédraogo-Traoré, Lorenzo Pezzoli, Mamoudou H. Djingarey, Nehémie Mbakuliyemo, Patrick L.F. Zuber,